发明名称 C7-fluoro substituted tetracycline compounds
摘要 The present invention is directed to a compound represented by Structural Formula (A):; or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.
申请公布号 US8906887(B2) 申请公布日期 2014.12.09
申请号 US200912462795 申请日期 2009.08.07
申请人 Tetraphase Pharmaceuticals, Inc. 发明人 Zhou Jingye;Xiao Xiao-Yi;Plamondon Louis;Hunt Diana Katharine;Clark Roger B.;Zahler Robert B.
分类号 A61K31/65;C07C237/26;C07D233/61;C07D207/34;C07D295/088;C07D211/60;C07D257/04;C07D295/15;C07D209/94;C07D231/14;A61K45/06;C07D207/14;C07D333/34;C07C311/08;C07D231/56;C07C311/21;C07D207/10;C07D413/12;C07D213/81;C07D249/04;C07D261/20;C07D207/09;C07D239/42;C07D333/38;C07D277/56;C07D207/08;C07D231/12;C07D207/12;C07D213/82;C07D205/04;C07D295/26;C07D207/16;C07D261/18;C07D211/76;C07D213/74 主分类号 A61K31/65
代理机构 Hamilton, Brook, Smith & Reynolds, P.C. 代理人 Hamilton, Brook, Smith & Reynolds, P.C.
主权项 1. A solid pharmaceutical composition comprising a compound represented by the following structural formula: or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier, wherein the compound is present in an amount effective to treat bacterial infections in a range from about 0.5 milligrams to about 500 milligrams.
地址 Watertown MA US